These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3868701)

  • 1. Relationship of DNA ploidy, cell kinetics, estrogen receptor and clinical status in patients with breast cancer.
    Kuo SH; Lin CC; Yu SC; Liaw KY; Wei TC; Chen KM
    Taiwan Yi Xue Hui Za Zhi; 1985 Nov; 84(11):1260-9. PubMed ID: 3868701
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow cytometry and cytomorphology in primary resectable breast cancer.
    Bedrossian CW; Raber M; Barlogie B
    Anal Quant Cytol; 1981 Jun; 3(2):112-6. PubMed ID: 6266303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy of human breast cancer.
    Del Bino G; Silvestrini R; Zucconi MR; Marchese G; Valentinis B; Di Fronzo G; Andreola S
    Anal Cell Pathol; 1989 Aug; 1(4):215-23. PubMed ID: 2487046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.
    Stål O; Wingren S; Carstensen J; Rutqvist LE; Skoog L; Klintenberg C; Nordenskjöld B
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):301-9. PubMed ID: 2702984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of age on the DNA ploidy levels of breast tumours.
    Taylor IW; Musgrove EA; Friedlander ML; Foo MS; Hedley DW
    Eur J Cancer Clin Oncol; 1983 May; 19(5):623-8. PubMed ID: 6683634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.
    Harvey J; de Klerk N; Berryman I; Sterrett G; Byrne M; Papadimitriou J
    Breast Cancer Res Treat; 1987; 9(2):101-9. PubMed ID: 3304476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of estrogen receptor status to DNA ploidy in breast cancer.
    Tsuchiya A; Nihei M; Ando Y; Suzuki S; Kimijima I; Abe R
    Surg Today; 1992; 22(2):105-9. PubMed ID: 1498488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
    Friedman NS; Freedman MD
    Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
    Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
    Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ploidy, proliferative activity and estrogen receptor content in human breast cancer.
    Raber MN; Barlogie B; Latreille J; Bedrossian C; Fritsche H; Blumenschein G
    Cytometry; 1982 Jul; 3(1):36-41. PubMed ID: 7117052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nuclear DNA content in breast cancer--relation between ploidy and lymph node metastasis].
    Nishi T; Okajima K; Fujiwara A; Yasuda M; Yamada S; Taguchi T; Sekimoto T
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):103-7. PubMed ID: 3701162
    [No Abstract]   [Full Text] [Related]  

  • 12. Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor.
    Olszewski W; Darzynkiewicz Z; Rosen PP; Schwartz MK; Melamed MR
    Cancer; 1981 Aug; 48(4):980-4. PubMed ID: 7272940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear DNA content in breast carcinoma with special reference to the parameters of malignant potentiality.
    Suehiro S; Hamada Y; Toi M; Nakamura T; Niimoto M; Hattori T
    Jpn J Surg; 1990 Jan; 20(1):115-8. PubMed ID: 2304282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiated DNA analysis in relation to steroid receptor status, grading, and staging in human breast cancer.
    Meckenstock G; Bojar H; Hort W
    Anticancer Res; 1987; 7(4B):749-54. PubMed ID: 3674762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
    Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
    Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flow cytometric analysis of DNA ploidy pattern in breast cancer: malignant potential and prognostic implication].
    Hara S; Tomita M
    Nihon Rinsho; 1992 Oct; 50(10):2444-9. PubMed ID: 1447815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer.
    Lipponen P; Eskelinen M; Papinaho S; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
    Anticancer Res; 1992; 12(3):677-82. PubMed ID: 1622125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Project Collaborative Group.
    Bergers E; van Diest PJ; Baak JP
    Cancer; 1996 Jun; 77(11):2258-66. PubMed ID: 8635093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy and survival in breast cancer patients.
    Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
    Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.